Login
Cart
Support
Search
Search
×
Oncology Congress
Search
Search
Search
Advanced Filters
Integrating the Latest Evidence on Immune Checkpoint Inhibitors Into the Management of Advanced Non-Small Cell Lung Cancer
Date
September 24, 2022
Speakers
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Mark G. Kris
,
MD
Attending Physician
,
Memorial Sloan Kettering Cancer Center
Evolving Treatment Paradigms in HR-Positive, HER2-Negative Breast Cancer: Integrating the Latest Evidence Into Clinical Practice
Date
September 24, 2022
Speakers
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Harold J. Burstein
,
MD, PhD
Medical Oncologist
,
Dana-Farber Cancer Institute
BREAK #1
Date
September 24, 2022
Management of Urothelial Carcinoma: Strategies for Addressing Health Disparities and Promoting Equitable Care
Date
September 24, 2022
Speakers
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Matthew D. Galsky
,
MD
Director, Genitourinary Medical Oncology
,
Mount Sinai Hospital
Mitigating Disparities in Prostate Cancer Care: Strategies to Promote Equitable Care Across the Continuum
Date
September 24, 2022
Speakers
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Matthew R. Smith
,
MD, PhD
Director, Genitourinary Malignancies Program
,
Massachusetts General Hospital Cancer Center
BREAK #2
Date
September 24, 2022
Overcoming Barriers to Equitable Care in Hepatocellular Carcinoma: Integrating New Evidence Into Clinical Practice
Date
September 24, 2022
Speakers
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Ghassan K. Abou-Alfa
,
MD, MBA
Attending Physician
,
Memorial Sloan Kettering Cancer Center
Updates in the Diagnosis and Management of Chronic Lymphocytic Leukemia: Strategies for Addressing Disparities in Patient Care and Outcomes
Date
September 24, 2022
Speakers
Chris Prakash
,
MD
Medical Director
,
Texas Oncology - Paris
Matthew S. Davids
,
MD, MMSc
Director of Clinical Research, Division of Lymphoma
,
Dana-Farber Cancer Institute
×
Evaluation